CD47 and atherosclerosis: Signal regulatory protein α is primarily localized in macrophages within atherosclerotic arteries, while CD47 is strongly localized in the necrotic core of plaques (61, 62).CD47 Inhibition therapy reduces atherosclerosis by restoring efferocytosis in plaques, removing apoptotic vascular smooth muscle and foam cells (61, 77) (Figure 2).